 Thomas Delong
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantigens | 17 | 2026 | 427 | 3.840 |
Why?
| | Insulin | 14 | 2026 | 2510 | 2.670 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2026 | 3918 | 2.420 |
Why?
| | CD4-Positive T-Lymphocytes | 19 | 2026 | 1138 | 2.340 |
Why?
| | Peptides | 11 | 2026 | 997 | 2.150 |
Why?
| | Insulin-Secreting Cells | 9 | 2026 | 392 | 2.040 |
Why?
| | C-Peptide | 6 | 2026 | 190 | 1.650 |
Why?
| | Islets of Langerhans | 8 | 2026 | 846 | 1.160 |
Why?
| | Mice, Inbred NOD | 14 | 2026 | 613 | 1.000 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2025 | 174 | 0.960 |
Why?
| | Secretory Vesicles | 1 | 2024 | 24 | 0.840 |
Why?
| | Chromogranin A | 5 | 2018 | 43 | 0.780 |
Why?
| | Epitopes | 7 | 2025 | 473 | 0.760 |
Why?
| | Mass Spectrometry | 4 | 2023 | 728 | 0.690 |
Why?
| | Islet Amyloid Polypeptide | 4 | 2018 | 48 | 0.680 |
Why?
| | Tandem Mass Spectrometry | 2 | 2020 | 571 | 0.640 |
Why?
| | T-Lymphocytes | 5 | 2025 | 1993 | 0.630 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2021 | 673 | 0.540 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2016 | 199 | 0.510 |
Why?
| | Mice | 16 | 2026 | 18303 | 0.460 |
Why?
| | Cathepsin D | 2 | 2026 | 20 | 0.420 |
Why?
| | Animals | 20 | 2026 | 37952 | 0.400 |
Why?
| | Peptide Fragments | 5 | 2022 | 693 | 0.370 |
Why?
| | Amino Acid Sequence | 5 | 2020 | 2127 | 0.360 |
Why?
| | Autoimmunity | 7 | 2024 | 932 | 0.360 |
Why?
| | Immune Tolerance | 2 | 2026 | 385 | 0.300 |
Why?
| | Proinsulin | 1 | 2025 | 52 | 0.230 |
Why?
| | Protein Precursors | 1 | 2025 | 136 | 0.220 |
Why?
| | Aspartic Acid | 1 | 2023 | 88 | 0.200 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 47 | 0.190 |
Why?
| | HLA-DQ Antigens | 3 | 2021 | 174 | 0.180 |
Why?
| | Chromatography, Liquid | 2 | 2020 | 450 | 0.180 |
Why?
| | In Vitro Techniques | 1 | 2023 | 1048 | 0.170 |
Why?
| | Humans | 16 | 2026 | 145140 | 0.170 |
Why?
| | Proteomics | 2 | 2022 | 1185 | 0.170 |
Why?
| | HLA-DRB1 Chains | 1 | 2020 | 110 | 0.150 |
Why?
| | Clone Cells | 2 | 2018 | 263 | 0.150 |
Why?
| | Autoantibodies | 1 | 2025 | 1508 | 0.130 |
Why?
| | Recombination, Genetic | 1 | 2018 | 203 | 0.130 |
Why?
| | HLA-A2 Antigen | 1 | 2016 | 36 | 0.120 |
Why?
| | Cells, Cultured | 5 | 2018 | 4142 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 573 | 0.120 |
Why?
| | Proteome | 1 | 2020 | 512 | 0.110 |
Why?
| | Transglutaminases | 2 | 2013 | 159 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2016 | 2881 | 0.100 |
Why?
| | CD4 Antigens | 1 | 2013 | 137 | 0.100 |
Why?
| | Cytokines | 1 | 2020 | 2048 | 0.090 |
Why?
| | Mice, Knockout | 5 | 2021 | 3114 | 0.090 |
Why?
| | Chromatography, Gel | 1 | 2012 | 130 | 0.090 |
Why?
| | Flow Cytometry | 2 | 2015 | 1159 | 0.090 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 159 | 0.080 |
Why?
| | Female | 7 | 2026 | 78636 | 0.080 |
Why?
| | Prediabetic State | 1 | 2013 | 247 | 0.080 |
Why?
| | Young Adult | 3 | 2025 | 14176 | 0.070 |
Why?
| | Adolescent | 4 | 2025 | 22479 | 0.070 |
Why?
| | Child | 4 | 2025 | 22670 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2185 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2021 | 364 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2504 | 0.050 |
Why?
| | Adoptive Transfer | 2 | 2015 | 199 | 0.050 |
Why?
| | Adult | 4 | 2025 | 40665 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1131 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1261 | 0.050 |
Why?
| | Male | 5 | 2025 | 72664 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2021 | 115 | 0.040 |
Why?
| | Cricetulus | 1 | 2021 | 118 | 0.040 |
Why?
| | CHO Cells | 1 | 2021 | 169 | 0.040 |
Why?
| | K562 Cells | 1 | 2021 | 92 | 0.040 |
Why?
| | Digestion | 1 | 2020 | 10 | 0.040 |
Why?
| | Asparagine | 1 | 2020 | 35 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 247 | 0.040 |
Why?
| | Amides | 1 | 2020 | 101 | 0.040 |
Why?
| | Cross Reactions | 1 | 2020 | 130 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2016 | 917 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 740 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 665 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2018 | 58 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2018 | 123 | 0.030 |
Why?
| | Mice, SCID | 1 | 2018 | 369 | 0.030 |
Why?
| | Microsatellite Repeats | 1 | 2015 | 156 | 0.030 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 468 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2021 | 1479 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2013 | 123 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 5972 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2013 | 172 | 0.020 |
Why?
| | Spleen | 1 | 2013 | 507 | 0.020 |
Why?
| | Pancreas | 1 | 2013 | 341 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2013 | 502 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2857 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2015 | 866 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 219 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1474 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 4282 | 0.020 |
Why?
| | Middle Aged | 1 | 2025 | 36126 | 0.010 |
Why?
|
|
Delong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|